This is the schedule used to deliver educational content offered by JHSPH. As a result, some of the information and/or materials listed here may not be relevant to or available for an OCW user's self-directed study.
| |
| 1 |
The Global Context of Pharmaceutical Products and Underserved Populations
- Become familiar with the key components and sequence of the Drug Management Cycle
- Understand the leading patient, product and pharmaceutical services management
- Describe the main functions of managing the pharmaceutical supply system
- Identify access barriers arising from globalization and the interrelationships between developed and developing countries
- Identify some key characteristics of underserved populations
- Understand the barrier to access of pharmaceuticals by underserved populations
|
Lecture
|
| 2 |
International Policy and Legal Framework
- Describe the main features of the World Trade Organization (WTO) and its actions regarding pharmaceutical products
- Discuss the main concerns regarding bilateral trade agreements
- Understand Orphan Drugs and be able to assess the effectiveness of policies designed to encouraged their development and marketing
- Explain Trade-Related Aspects of Intellectual Property (TRIPs) in relation to access and cost of pharmaceuticals
|
Lecture |
| 3 |
Drug Manufacture, Industrial Pharmacy Considerations, Quality Assurance and Regulation
- Be familiar with drug manufacturing requirements and industry regulations
- Describe Good Manufacturing Practices (GMP)
- Understand requirements for developing domestic manufacturing capabilities
- Differentiate between brand vs generics and the conditions for interchange
- Become familiar with the procedures to prevent and detect counterfeit products
- Describe relevant drug regulations
- Describe the Guiding Principles for small national drug regulatory authorities
- Describe relevant drug regulations
- Understand basics of and issues relating to drug product quality assurance
- Understand differences relating to full-scale manufacturing, small-scale institutional/local production, and extemporaneous compounding
|
Lecture |
| 4 |
The Drug Management Cycle: Selection
- Be able to apply evidence-based criteria for pharmaceutical product selection
- Describe approaches to developing Essential Medicines Lists, Formularies, and Standard Treatment Guidelines
- Recognize the challenges in implementing treatment guidelines and formulary systems and ways to overcome them
|
Lecture |
| 5 |
Forecasting and Quantification
- Discuss the critical issues in forecasting and quantifying drug requirements
- Explain the four general methods for quantification
- Apply the consumption-based method to estimate actual need and costs
- Develop a basic spreadsheet for budget and forecasting models
- Become aware of the potential of MSH's Quantimed software to project drug needs
|
Laboratory |
| 6 |
The Drug Management Cycle: Procurement
- Explain the factors influencing drug prices and total costs
- Understand different types of procurement
- Describe good pharmaceutical procurement practices
- Describe the tender process
- Describe the steps in the tender cycle and related critical management consideration
- Explain the process for developing a contract for services
- Identify the procurement-related determinants of drug quality and the process(es) for obtaining quality drugs
|
Lecture |
| 7 |
Drug Donations
- Explain the core principles for drug donations
- Discuss the main concerns regarding drug donations
|
Lecture |
| 8 |
The Drug Management Cycle: Distribution
- Explain the critical elements in designing a distribution system
- Understand the port clearing process and key documents
- Discuss the main considerations for managing medical stores independent of health facilities
- Explain inventory processes within health facilities
- Logistic management of drug distribution chains: transport, storage warehousing, customs and Kit System.
- Describe standard reports used to manage inventory
- Explain safety stock and service levels in determining inventory practices
- Apply the EOQ model for reordering
|
Lecture |
| 9 |
The Drug Management Cycle: Use
- Define rational drug use
- Explain the main factors contributing to irrational drug use
- Discuss the steps in developing strategies to improve drug use
- Apply data and quantitative methods to identify drug interventions
- Evaluate drug information sources
- Understand drug promotion
- Explain the framework for improving drug prescribing - including educational, managerial and regulatory approaches
- Describe the steps in good dispensing practice(s)
- Identify the process for public education in appropriate drug use
- Discuss the role(s) of Medicinal Plants and Traditional Healers
|
Lecture |
| 10 |
Budgeting and Cost Control
- Be able to develop a spreadsheet of:
- budget
- budget impact
- forecast(s)
- breakeven analysis
|
Laboratory |
| 11 |
Access to Essential Drugs
- Explain how to appraise access to essential drugs at the community level
- Understand the different dimensions and determinants of access to medicines
- Describe different types of community participation that affect access to essential medicines
- Describe how to do a community needs assessment
- Describe recent innovations to increase access to medicines involving the private sector and communities, including participatory monitoring
- Explain the main factors influencing cost, use and access to pharmaceuticals
|
Lecture |
| 12 |
Management Support Systems: Planning Cycle
- Explain the management cycle and implementation strategies
- Apply Gantt charts as a work planning tools
- Design a monitoring system and appropriate indicators
|
Lecture |
| 13 |
Pharmaceutical Care and Drug Utilization in an HIV/AIDS Clinic
- Understand the terminology and concepts used in DUR
- Be able to explain models for prospective DUR and for retrospective DUR
- Be able to discuss DUR applications to detect inappropriate drug use in addition to fraud and abuse
|
Lecture |
| 14 |
Financing and Sustainability
- Explain the different types of financing and assistance
- {Discuss strategic considerations in product pricing from the perspective of the manufacturer and distributor}
- Discuss the revolving fund concept
|
Planning Laboratory |